688580 伟思医疗
已收盘 11-06 15:00:00
资讯
新帖
简况
伟思医疗(688580)11月2日主力资金净卖出103.51万元
证券之星 · 11-03
伟思医疗(688580)11月2日主力资金净卖出103.51万元
【机构调研记录】浙商基金调研博力威、伟思医疗等3只个股(附名单)
证券之星 · 10-29
【机构调研记录】浙商基金调研博力威、伟思医疗等3只个股(附名单)
伟思医疗(688580)2026年三季报简析:净利润同比增长21.36%
证券之星 · 10-28
伟思医疗(688580)2026年三季报简析:净利润同比增长21.36%
伟思医疗:10月27日召开业绩说明会,包括知名机构淡水泉的多家机构参与
证券之星 · 10-28
伟思医疗:10月27日召开业绩说明会,包括知名机构淡水泉的多家机构参与
伟思医疗(688580)10月27日主力资金净卖出721.52万元
证券之星 · 10-28
伟思医疗(688580)10月27日主力资金净卖出721.52万元
伟思医疗(688580.SH)发布前三季度业绩,归母净利润1.24亿元,同比增长21.36%
智通财经 · 10-26
伟思医疗(688580.SH)发布前三季度业绩,归母净利润1.24亿元,同比增长21.36%
伟思医疗(688580)9月30日股东户数0.92万户,较上期增加7.76%
证券之星 · 10-26
伟思医疗(688580)9月30日股东户数0.92万户,较上期增加7.76%
伟思医疗(688580)10月22日主力资金净卖出91.49万元
证券之星 · 10-23
伟思医疗(688580)10月22日主力资金净卖出91.49万元
伟思医疗(688580)10月20日主力资金净买入370.68万元
证券之星 · 10-21
伟思医疗(688580)10月20日主力资金净买入370.68万元
10月20日伟思医疗涨5.63%,创金合信大健康混合A基金重仓该股
证券之星 · 10-20
10月20日伟思医疗涨5.63%,创金合信大健康混合A基金重仓该股
伟思医疗(688580)发布关于召开2026年第三季度业绩说明会的公告,10月16日股价上涨1.02%
证券之星 · 10-16
伟思医疗(688580)发布关于召开2026年第三季度业绩说明会的公告,10月16日股价上涨1.02%
伟思医疗公告:股东拟于9月24日至12月22日期间减持不超过总股本2%股份
美股速递 · 09-02
伟思医疗公告:股东拟于9月24日至12月22日期间减持不超过总股本2%股份
【机构调研记录】浙商基金调研我武生物、伟思医疗
证券之星 · 08-31
【机构调研记录】浙商基金调研我武生物、伟思医疗
股市必读:伟思医疗(688580)8月28日披露最新机构调研信息
证券之星 · 08-31
股市必读:伟思医疗(688580)8月28日披露最新机构调研信息
伟思医疗(688580)2026年中报简析:营收净利润同比双双增长,盈利能力上升
证券之星 · 08-27
伟思医疗(688580)2026年中报简析:营收净利润同比双双增长,盈利能力上升
伟思医疗(688580)6月30日股东户数0.85万户,较上期减少16.98%
证券之星 · 08-26
伟思医疗(688580)6月30日股东户数0.85万户,较上期减少16.98%
伟思医疗2026年半年报:资产处置增厚利润,扣非净利增速平缓
蓝鲸财经 · 08-26
伟思医疗2026年半年报:资产处置增厚利润,扣非净利增速平缓
图解伟思医疗中报:第二季度单季净利润同比增长6.77%
证券之星 · 08-26
图解伟思医疗中报:第二季度单季净利润同比增长6.77%
伟思医疗(688580)披露2026年半年度报告,8月25日股价上涨2.67%
证券之星 · 08-25
伟思医疗(688580)披露2026年半年度报告,8月25日股价上涨2.67%
伟思医疗:净利高增超四成 激光射频业务乘势而起
中国财富通 · 08-25
伟思医疗:净利高增超四成 激光射频业务乘势而起
加载更多
公司概况
公司名称:
南京伟思医疗科技股份有限公司
所属行业:
专用设备制造业
上市日期:
2020-07-21
主营业务:
南京伟思医疗科技股份有限公司的主营业务是医疗器械的研发、生产和销售。公司的主要产品是经颅磁刺激仪、盆底磁刺激仪、脉冲磁场治疗仪、脉冲磁恢复仪、脉冲磁塑形仪、生物刺激反馈仪、立体动态干扰电治疗仪、多参数生物反馈仪、团体生物反馈仪、新生儿脑电测量仪、高频电灼仪、皮秒激光治疗仪、钬激光治疗仪和强脉冲光治疗仪、康复机器人、阴道电极、直肠电极、盆底训练探头、盆底肌肉康复器、高频电极、治疗激光用石英光纤、一次性医用激光光纤、认知功能障碍治疗软件、伟思云。
发行价格:
67.58
{"stockData":{"symbol":"688580","market":"SH","secType":"STK","nameCN":"伟思医疗","latestPrice":38.26,"timestamp":1793948400000,"preClose":39.25,"halted":0,"volume":805577,"delay":0,"changeRate":-0.0252,"floatShares":95771299,"shares":95771299,"eps":1.6696,"marketStatus":"已收盘","change":-0.99,"latestTime":"11-06 15:00:00","open":37.93,"high":39.1,"low":37.93,"amount":30961100,"amplitude":0.0298,"askPrice":38.31,"askSize":5,"bidPrice":38.26,"bidSize":36,"shortable":0,"etf":0,"ttmEps":1.6696,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794187800000},"marketStatusCode":5,"adr":0,"adjPreClose":39.25,"symbolType":"stock_kcb","openAndCloseTimeList":[[1793928600000,1793935800000],[1793941200000,1793948400000]],"highLimit":43.18,"lowLimit":35.33,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":95771288,"isCdr":false,"pbRate":2.14,"roa":"--","peRate":22.915668,"roe":"7.21%","epsLYR":1.44,"committee":0.867868,"marketValue":3664000000,"turnoverRate":0.0084,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2026-11-09。","afterMarket":{"amount":0,"volume":0,"close":38.26,"buyVolume":4000,"sellVolume":0,"time":1793950437746,"indexStatus":"已收盘 11-06 15:30:00","preClose":39.25},"floatMarketCap":3664000000},"requestUrl":"/m/hq/s/688580","defaultTab":"news","newsList":[{"id":"2680792059","title":"伟思医疗(688580)11月2日主力资金净卖出103.51万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2680792059","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680792059?lang=zh_cn&edition=full","pubTime":"2026-11-03 08:48","pubTimestamp":1793666888,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月2日收盘,伟思医疗报收于38.06元,下跌0.63%,换手率1.59%,成交量1.52万手,成交额5690.42万元。11月2日的资金流向数据方面,主力资金净流出103.51万元,占总成交额1.82%,游资资金净流入162.1万元,占总成交额2.85%,散户资金净流出58.58万元,占总成交额1.03%。近5日资金流向一览见下表:伟思医疗融资融券信息显示,融资方面,当日融资买入641.69万元,融资偿还811.83万元,融资净偿还170.14万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110300010677.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688580","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679445011","title":"【机构调研记录】浙商基金调研博力威、伟思医疗等3只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2679445011","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679445011?lang=zh_cn&edition=full","pubTime":"2026-10-29 08:16","pubTimestamp":1793233000,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及10月28日披露的机构调研信息,浙商基金近期对3家上市公司进行了调研,相关名单如下:1)博力威 调研纪要:Vinfast自7月实现量产出货,已成为公司第一大客户,相关产品处于产能爬坡阶段,预计明年出货量将进一步提升。三季度毛利率下滑主要因Vinfast产品处于爬产阶段,后续有望回升。公司实行季度调价机制应对碳酸锂价格上涨,成本传导顺畅。电生理下滑因高基数与医保扰动,属阶段性调整,TMS可对冲波动。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900012471.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688345","BK0224","BK0251","688580"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678846772","title":"伟思医疗(688580)2026年三季报简析:净利润同比增长21.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678846772","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678846772?lang=zh_cn&edition=full","pubTime":"2026-10-28 20:17","pubTimestamp":1793189854,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期伟思医疗发布2026年三季报。根据财报显示,伟思医疗净利润同比增长21.36%。截至本报告期末,公司营业总收入3.25亿元,同比下降0.18%,归母净利润1.24亿元,同比上升21.36%。按单季度数据看,第三季度营业总收入9849.49万元,同比下降14.41%,第三季度归母净利润2384.52万元,同比下降27.35%。去年的净利率为29.84%,算上全部成本后,公司产品或服务的附加值高。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800046915.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688580"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678467632","title":"伟思医疗:10月27日召开业绩说明会,包括知名机构淡水泉的多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2678467632","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678467632?lang=zh_cn&edition=full","pubTime":"2026-10-28 20:01","pubTimestamp":1793188909,"startTime":"0","endTime":"0","summary":"同时,结合当前市场环境,公司主动优化订单结构、降低经营杠杆,审慎承接低毛利订单,优先保障盈利质量与毛利率水平,是前三季度整体收入基本持平的核心原因。4整体而言,康复业务仍是公司基本盘,将持续为公司贡献利润与经营性现金流。该股最近90天内共有2家机构给出评级,买入评级1家,增持评级1家;过去90天内机构目标均价为52.0。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800045908.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688580","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678411480","title":"伟思医疗(688580)10月27日主力资金净卖出721.52万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2678411480","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678411480?lang=zh_cn&edition=full","pubTime":"2026-10-28 08:46","pubTimestamp":1793148397,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月27日收盘,伟思医疗报收于38.85元,下跌5.98%,换手率2.09%,成交量2.01万手,成交额7946.75万元。10月27日的资金流向数据方面,主力资金净流出721.52万元,占总成交额9.08%,游资资金净流入1447.17万元,占总成交额18.21%,散户资金净流出725.65万元,占总成交额9.13%。融券方面,融券卖出0.0股,融券偿还0.0股,融券余量6528.0股,融券余额25.36万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800014254.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688580","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678162958","title":"伟思医疗(688580.SH)发布前三季度业绩,归母净利润1.24亿元,同比增长21.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678162958","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678162958?lang=zh_cn&edition=full","pubTime":"2026-10-26 18:52","pubTimestamp":1793011946,"startTime":"0","endTime":"0","summary":"智通财经APP讯,伟思医疗(688580.SH)披露2026年第三季度报告,前三季度公司实现营业收入3.25亿元,同比下降0.18%;归母净利润1.24亿元,同比增长21.36%;扣非净利润8828万元,同比下降5.68%;基本每股收益1.30元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1512583.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688580"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678516995","title":"伟思医疗(688580)9月30日股东户数0.92万户,较上期增加7.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678516995","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678516995?lang=zh_cn&edition=full","pubTime":"2026-10-26 17:53","pubTimestamp":1793008436,"startTime":"0","endTime":"0","summary":"证券之星消息,近日伟思医疗披露,截至2026年9月30日公司股东户数为9212.0户,较6月30日增加663.0户,增幅为7.76%。在医疗器械行业个股中,伟思医疗股东户数低于行业平均水平,截至9月30日,医疗器械行业平均股东户数为2.07万户。从股价来看,2026年6月30日至2026年9月30日,伟思医疗区间跌幅为20.69%,在此期间股东户数增加663.0户,增幅为7.76%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600024105.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688580"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677691810","title":"伟思医疗(688580)10月22日主力资金净卖出91.49万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677691810","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677691810?lang=zh_cn&edition=full","pubTime":"2026-10-23 08:21","pubTimestamp":1792714907,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月22日收盘,伟思医疗报收于40.29元,下跌0.17%,换手率1.16%,成交量1.11万手,成交额4511.63万元。10月22日的资金流向数据方面,主力资金净流出91.49万元,占总成交额2.03%,游资资金净流入163.53万元,占总成交额3.62%,散户资金净流出72.04万元,占总成交额1.6%。融券方面,融券卖出500.0股,融券偿还0.0股,融券余量6728.0股,融券余额27.11万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300007479.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688580"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677610470","title":"伟思医疗(688580)10月20日主力资金净买入370.68万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677610470","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677610470?lang=zh_cn&edition=full","pubTime":"2026-10-21 08:19","pubTimestamp":1792541953,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月20日收盘,伟思医疗报收于40.88元,上涨5.63%,换手率1.68%,成交量1.61万手,成交额6552.68万元。10月20日的资金流向数据方面,主力资金净流入370.68万元,占总成交额5.66%,游资资金净流出397.4万元,占总成交额6.06%,散户资金净流入26.72万元,占总成交额0.41%。融券方面,融券卖出600.0股,融券偿还200.0股,融券余量6375.0股,融券余额26.06万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100006946.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688580"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676665514","title":"10月20日伟思医疗涨5.63%,创金合信大健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2676665514","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676665514?lang=zh_cn&edition=full","pubTime":"2026-10-20 16:29","pubTimestamp":1792484948,"startTime":"0","endTime":"0","summary":"证券之星消息,10月20日伟思医疗涨5.63%,收盘报40.88元,换手率1.68%,成交量1.61万手,成交额6552.68万元。根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为创金合信基金的创金合信大健康混合A。创金合信大健康混合A目前规模为0.28亿元,最新净值0.5861,较上一交易日上涨0.48%,近一年下跌22.73%。创金合信大健康混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102000024483.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688580"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675608518","title":"伟思医疗(688580)发布关于召开2026年第三季度业绩说明会的公告,10月16日股价上涨1.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675608518","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675608518?lang=zh_cn&edition=full","pubTime":"2026-10-16 22:33","pubTimestamp":1792161219,"startTime":"0","endTime":"0","summary":"截至2026年10月16日收盘,伟思医疗报收于38.8元,较前一交易日上涨1.02%,最新总市值为37.16亿元。该股当日开盘39.1元,最高39.88元,最低38.52元,成交额达4323.23万元,换手率为1.15%。公告显示,公司将于2026年11月5日14:00-15:00通过上证路演中心网络互动方式召开2026年第三季度业绩说明会,介绍公司经营成果、财务状况及战略规划等内容。投资者可于2026年10月29日至11月4日17:00前通过上证路演中心网站或公司邮箱ir@vishee.com提交问题。说明会结束后可通过该平台查看会议内容。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600040564.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688580","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113241711","title":"伟思医疗公告:股东拟于9月24日至12月22日期间减持不超过总股本2%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1113241711","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113241711?lang=zh_cn&edition=full","pubTime":"2026-09-02 18:54","pubTimestamp":1788346456,"startTime":"0","endTime":"0","summary":"南京伟思医疗科技股份有限公司发布公告,披露了一项重要股东动向。根据公告内容,该公司的一位股东计划在2025年9月24日至12月22日这一时间窗口内,减持其所持有的公司股份,最高比例可达总股本的2%。伟思医疗作为国内康复医疗器械领域的知名企业,其股东结构变动历来受到市场密切关注。此次减持计划的详细执行情况,包括具体减持价格区间、交易方式等关键要素,将取决于届时市场实际状况以及股东的最终操作决策。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688580","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663028138","title":"【机构调研记录】浙商基金调研我武生物、伟思医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2663028138","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663028138?lang=zh_cn&edition=full","pubTime":"2026-08-31 08:03","pubTimestamp":1788134630,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及8月28日披露的机构调研信息,浙商基金近期对2家上市公司进行了调研,相关名单如下:1)我武生物 调研纪要:公司上半年营收和利润受到增值税政策调整影响,粉尘螨滴剂等产品税率由3%升至13%,叠加去年同期高基数,增速有所放缓。浙商基金成立于2010年,截至目前,资产管理规模254.44亿元,排名115/212;资产管理规模197.56亿元,排名110/212;管理公募基金数76只,排名83/212;旗下公募基金经理13人,排名97/212。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100002156.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0251","300357","688580"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663406740","title":"股市必读:伟思医疗(688580)8月28日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2663406740","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663406740?lang=zh_cn&edition=full","pubTime":"2026-08-31 06:57","pubTimestamp":1788130628,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘,伟思医疗报收于46.08元,下跌2.48%,换手率1.33%,成交量1.28万手,成交额5952.61万元。机构调研要点:公司已累计取得11张海外注册证,核心产品进入乌兹别克斯坦、哥伦比亚、墨西哥及中国台湾等地区,国际化销售网络初步搭建。交易信息汇总资金流向8月28日主力资金净流出648.88万元,占总成交额10.9%;游资资金净流入1136.33万元,占总成交额19.09%;散户资金净流出487.45万元,占总成交额8.19%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100001719.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688580","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662784740","title":"伟思医疗(688580)2026年中报简析:营收净利润同比双双增长,盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2662784740","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662784740?lang=zh_cn&edition=full","pubTime":"2026-08-27 06:20","pubTimestamp":1787782820,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期伟思医疗发布2026年中报。截至本报告期末,公司营业总收入2.26亿元,同比上升7.59%,归母净利润1.0亿元,同比上升44.43%。本报告期伟思医疗盈利能力上升,毛利率同比增幅0.33%,净利率同比增幅34.23%。去年的净利率为29.84%,算上全部成本后,公司产品或服务的附加值高。本文数据来源于伟思医疗2026年中报,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700011453.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688580"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662941067","title":"伟思医疗(688580)6月30日股东户数0.85万户,较上期减少16.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662941067","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662941067?lang=zh_cn&edition=full","pubTime":"2026-08-26 17:37","pubTimestamp":1787737061,"startTime":"0","endTime":"0","summary":"证券之星消息,近日伟思医疗披露,截至2026年6月30日公司股东户数为8549.0户,较3月31日减少1748.0户,减幅为16.98%。在医疗器械行业个股中,伟思医疗股东户数低于行业平均水平,截至6月30日,医疗器械行业平均股东户数为2.13万户。从股价来看,2026年3月31日至2026年6月30日,伟思医疗区间涨幅为6.54%,在此期间股东户数减少1748.0户,减幅为16.98%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600039579.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688580"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662010766","title":"伟思医疗2026年半年报:资产处置增厚利润,扣非净利增速平缓","url":"https://stock-news.laohu8.com/highlight/detail?id=2662010766","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662010766?lang=zh_cn&edition=full","pubTime":"2026-08-26 09:47","pubTimestamp":1787708844,"startTime":"0","endTime":"0","summary":"蓝鲸新闻8月26日讯,8月25日,伟思医疗 公布2026年中报,公司依托康复主业与新兴医美、泌尿业务的双轮驱动战略,受益于核心产品销量增加及资产处置收益贡献,报告期业绩实现显著增长;同时,非经常性损益对利润影响较大,扣非净利润增速相对平缓。财报数据显示,报告期公司实现营业收入2.26亿元,同比增长7.59%;归母净利润1.00亿元,同比增长44.43%;扣非净利润0.67亿元,同比增长5.46%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1787707698847812827","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["688580","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662751095","title":"图解伟思医疗中报:第二季度单季净利润同比增长6.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662751095","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662751095?lang=zh_cn&edition=full","pubTime":"2026-08-26 03:28","pubTimestamp":1787686134,"startTime":"0","endTime":"0","summary":"证券之星消息,伟思医疗2026年中报显示,上半年度公司主营收入2.26亿元,同比上升7.59%;归母净利润1.0亿元,同比上升44.43%;扣非净利润6704.35万元,同比上升5.46%;其中2026年第二季度,公司单季度主营收入1.2亿元,同比上升5.11%;单季度归母净利润3854.94万元,同比上升6.77%;单季度扣非净利润3397.85万元,同比上升2.86%;负债率5.74%,投资收益583.44万元,财务费用-197.87万元,毛利率66.31%。财报数据概要请见下图:本文数据来源于伟思医疗2026年中报,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600005632.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688580"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662753494","title":"伟思医疗(688580)披露2026年半年度报告,8月25日股价上涨2.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662753494","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662753494?lang=zh_cn&edition=full","pubTime":"2026-08-25 22:52","pubTimestamp":1787669533,"startTime":"0","endTime":"0","summary":"截至2026年8月25日收盘,伟思医疗报收于46.9元,较前一交易日上涨2.67%,最新总市值为44.92亿元。近日,南京伟思医疗科技股份有限公司披露《2026年半年度报告》。本报告期实现营业收入226,437,246.19元,同比增长7.59%;利润总额114,315,750.47元,同比增长49.36%;归属于上市公司股东的净利润100,122,719.93元,同比增长44.43%;归属于上市公司股东的扣除非经常性损益的净利润67,043,515.85元,同比增长5.46%。研发投入占营业收入的比例为12.45%,较上年同期减少0.04个百分点。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500051954.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688580"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662730080","title":"伟思医疗:净利高增超四成 激光射频业务乘势而起","url":"https://stock-news.laohu8.com/highlight/detail?id=2662730080","media":"中国财富通","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662730080?lang=zh_cn&edition=full","pubTime":"2026-08-25 19:52","pubTimestamp":1787658734,"startTime":"0","endTime":"0","summary":"继一季度营收同比增长10.56%、净利润同比高增85.35%实现“开门红”后,伟思医疗二季度延续逐季向好态势。激光射频乘势而起,光秒协同构建一站式美肤方案2026年上半年,伟思医疗激光射频类收入同比增长35.79%,国产高端光电设备迎来加速替代窗口。精准+深部:定义全球经颅磁临床新高度报告期内,伟思医疗磁刺激类收入同比增长18.94%,在精神心理康复赛道持续领跑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=oUAHwVzJptY%3D","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0251","688580"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793996860821,"stockEarnings":[{"period":"1week","weight":-0.001},{"period":"1month","weight":-0.0944},{"period":"3month","weight":-0.2351},{"period":"6month","weight":-0.4012},{"period":"1year","weight":-0.2262},{"period":"ytd","weight":-0.1932}],"compareEarnings":[{"period":"1week","weight":0.0139},{"period":"1month","weight":-0.0502},{"period":"3month","weight":-0.0738},{"period":"6month","weight":-0.127},{"period":"1year","weight":-0.0895},{"period":"ytd","weight":-0.0805}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"南京伟思医疗科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"9212人(较上一季度增加7.76%)","perCapita":"10396股","listingDate":"2020-07-21","address":"江苏省南京市雨花台区硕果路1号","registeredCapital":"9577万元","survey":" 南京伟思医疗科技股份有限公司的主营业务是医疗器械的研发、生产和销售。公司的主要产品是经颅磁刺激仪、盆底磁刺激仪、脉冲磁场治疗仪、脉冲磁恢复仪、脉冲磁塑形仪、生物刺激反馈仪、立体动态干扰电治疗仪、多参数生物反馈仪、团体生物反馈仪、新生儿脑电测量仪、高频电灼仪、皮秒激光治疗仪、钬激光治疗仪和强脉冲光治疗仪、康复机器人、阴道电极、直肠电极、盆底训练探头、盆底肌肉康复器、高频电极、治疗激光用石英光纤、一次性医用激光光纤、认知功能障碍治疗软件、伟思云。","listedPrice":67.58},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"伟思医疗(688580)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供伟思医疗(688580)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"伟思医疗,688580,伟思医疗股票,伟思医疗股票老虎,伟思医疗股票老虎国际,伟思医疗行情,伟思医疗股票行情,伟思医疗股价,伟思医疗股市,伟思医疗股票价格,伟思医疗股票交易,伟思医疗股票购买,伟思医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"伟思医疗(688580)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供伟思医疗(688580)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}